Hackenbroich, Samantha
Kranke, Peter
Meybohm, Patrick
Weibel, Stephanie http://orcid.org/0000-0003-1900-2535
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 12 March 2022
Accepted: 4 August 2022
First Online: 26 August 2022
Declarations
:
: Not applicable
: Not applicable.
: PK has financial relationships with the Teva ratiopharm GmbH, Fresenius Kabi GmbH Germany, and PAJUNK that might have an interest in the submitted work in the previous 3 years; he has no other relationships or activities that could appear to have influenced the submitted work. PK was involved in the conduct of studies related to the Cochrane review. He did not assess the relevant studies for in- or exclusion and were not allowed to extract data and critically appraise the quality of the relevant studies. The other authors declare that they have no competing interests.